GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Value
Increase
Decrease
Funds Holding
3,213
Funds Holding Change
+192
Funds Holding Growth
+6%
Value
$594B
Holding in Top 10
682
Top 10 Change
+108
Top 10 Growth
+19%
Value Growth
-3%
New
336
Increased
1,136
Reduced
1,531
Closed
112
Capital Inflow
$24.2B
Capital Outflow
$21.5B
Net Capital Flow
+$2.64B
Capital Flow Change
+$13.9B
Calls
$5.72B
Puts
$6.54B
Net Calls
-$826M
Put/Call Ratio
1.14